CRC Research Update — May 24, 2026
Today's colorectal cancer research highlights
metastatic
A collection of 148 issues
CRC Research Finding
Skip to content
The CRC Digest
◆ Updated survival analysis for bevacizumab in metastatic CRC
(Clinical Colorectal Cancer)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care team.
© 2026 The CRC Digest —
crcdigest.com
CRC Research Update — May 13, 2026
Today's colorectal cancer research highlights
CRC Research Update — May 12, 2026
Today's colorectal cancer research highlights
Prolonged Response to Pembrolizumab in BRAF V600E MSS Colorectal Cancer
Skip to content
The CRC Digest
Prolonged Response to Pembrolizumab in BRAF V600E MSS Colorectal Cancer
A patient with BRAF V600E-mutant microsatellite-stable metastatic colorectal cancer achieved a prolonged response to pembrolizumab following a dynamic increase in tumor mutational burden. (The Oncologist)
This content is informational only and does not constitute
CRC Research Finding
Skip to content
The CRC Digest
◆ Sequential vs. Upfront Oxaliplatin in Metastatic Colorectal Cancer: Long-Term Results
(Communications Medicine)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care team.
© 2026 The CRC Digest —
crcdigest.com
CRC Research Update — April 20, 2026
Today's colorectal cancer research highlights
CRC Research Update — April 06, 2026
Today's colorectal cancer research highlights